Global Biosimilars Market is estimated to reach $46.0 Billion by 2025, Says Variant Market Research

1
Global Biosimilars Market is estimated to reach
46.0 Billion by 2025, Says Variant Market
Research

• Bhavana Patel
• Seo Analyst
• help_at_variantmarketresearch.com

2
Biosimilars Market

• Global Biosimilars market is estimated to reach
  46.0 Billion by 2025 growing at a CAGR of 33
  from 2017 to 2025. Biosimilars are the
  biotechnological product that is proved to be
  comparable to an already approved reference
  product in quality, non-clinical and clinical
  evaluation. The generic equivalents of biologics
  are meant as a biosimilars. A biosimilar is a
  highly similar, comparable version of an approved
  biologic medicine, which undergo through clinical
  trials to demonstrate that it works just as the
  approved biologic medicine. It is used to treat a
  wide range of conditions including cancer and
  autoimmune diseases. Regulatory guidelines for
  biosimilar development and approval are rigorous
  and undergoing constant refinement. Biosimilars
  offer good alternate treatment options in
  patients who cannot be treated with synthetic
  DMARDs (Disease-modifying antirheumatic drugs).
• Download Free Sample Copy of Report _at_
  https//www.variantmarketresearch.com/report-categ
  ories/pharmaceuticals/biosimilars-market/sample-re
  quest

Variant Market Research help_at_variantmarketresear
ch.com sales_at_variantmarketresearch.com
3
Global Biosimilars Market Size and Forecast, 2016
- 2025
4
Biosimilars Market

• Product, manufacturing type, disease and
  geography are the segment of biosimilars market.
  The product segment is categorized into
  recombinant non-glycosylated proteins (insulin,
  interferon, recombinant human growth hormone, and
  granulocyte colony-stimulating factor),
  recombinant glycosylated proteins
  (erythropoietin, follitropin, and monoclonal
  antibodies), and recombinant peptides (glucagon,
  and calcitonin). In-house manufacturing and
  contract manufacturing are the bifurcations of
  manufacturing type. Furthermore, oncology,
  chronic diseases, growth hormone deficiency,
  blood disorders, infectious diseases, autoimmune
  diseases, and other diseases are segregated under
  disease segment.
• Browse the Complete Report _at_ https//www.variantma
  rketresearch.com/report-categories/pharmaceuticals
  /biosimilars-market

5
Global Biosimilars Market, by Manufacturing Type
6
Top Key Players

• Celltrion Inc.
• Biocon
• Hospira Inc.
• Merck KGaA
• Biogen
• Genentech, Inc.
• LG Life Sciences
• Novartis AG
• Synthon, and Teva Pharmaceutical Industries Ltd.,
  among others.

7
Global Biosimilars Market Regional Revenue
8
The key takeaways from the report

• The report will provide detailed analysis of
  Global Biosimilars Market with respect to major
  segments such as product, manufacturing type,
  disease and geography
• The report will include the qualitative and
  quantitative analysis with market estimation over
  2016 2025 and compound annual growth rate
  (CAGR) between 2017 and 2025
• Comprehensive analysis of market dynamics
  including factors and opportunities will be
  provided in the report
• An exhaustive regional analysis of Global
  Biosimilars Market has been included in the
  report
• Profile of the key players in the Global
  Biosimilars Market will be provided, which
  include key financials, product services, new
  developments and business strategies

9
Global Biosimilars Market Primary Interviews, by
Geography
10
Scope of the Global Biosimilars Market

• Product Segments
• Recombinant Non-Glycosylated Proteins
• Insulin
• Interferon
• Recombinant Human Growth Hormone
• Granulocyte Colony-Stimulating Factor
• Recombinant Glycosylated Proteins
• Erythropoietin
• Follitropin
• Monoclonal Antibodies

11
Scope of the Global Biosimilars Market

• Product Segments
• Recombinant Peptides
• Glucagon
• Calcitonin
• Manufacturing Type Segments
• In-House Manufacturing
• Contract Manufacturing

12
Scope of the Global Biosimilars Market

• Disease Segments
• Oncology
• Chronic Diseases
• Growth Hormone Deficiency
• Blood Disorders
• Infectious Diseases
• Autoimmune Diseases
• Other Diseases

13
Scope of the Global Biosimilars Market

• Geographical Segments
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Rest of Europe

14
Scope of the Global Biosimilars Market

• Geographical Segments
• Asia-Pacific
• India
• China
• Japan
• South Korea
• Rest of Asia-Pacific
• RoW
• South America
• Middle East
• Africa

15
Table of Content

• Chapter 1 Prefix
• 1.1 Market Scope
• 1.2 Report Description
• 1.3 Research Methodology
• 1.3.1 Primary Research
• 1.3.2 Secondary Research
• 1.3.3 In-house Data Modeling
• Chapter 2 Executive Summary
• 2.1 Global Biosimilars Market Year-on-Year
  Growth, 2017 2025 ()

16
Table of Content

• Chapter 3 Market Outline
• 3.1 Market Inclination, Trend, Outlook and
  Viewpoint
• 3.2 Market Share Analysis Companys
  Competitive Scenario
• 3.3 Market Dynamics
• 3.3.1 Drivers
• 3.3.1.1 Impact Analysis
• 3.3.2 Restraints
• 3.3.2.1 Impact Analysis
• 3.3.3 Opportunities
• .....

17
Table of Content

• Chapter 8 Company Profiles
• 8.1 Celltrion Inc.
• 8.2 Biocon
• 8.3 Merck KGaA
• 8.4 BIOGEN
• 8.5 Genentech, Inc.
• 8.6 LG LIFE SCIENCES
• 8.7 Novartis AG
• 8.8 Synthon
• 8.9 Teva Pharmaceutical Industries Ltd.
• 8.10 Hospira Inc.

18
Contact Us

• John Dave,
• Head - Sales
• Variant Market Research
• 649 Mission St, 5th Floor, San Francisco, CA
  94105, United States.
• Tel [phone]
• Fax [phone]
• Email john.dave_at_variantmarketresearch.com
• Email help_at_variantmarketresearch.com

19

• Thank-You..